0 results found with selected filters. Please refine the filters. Redirecting to initial search..
Table "column sort" updates the order of the bars in the chart.
downloaded on: 2025/11/18 23:19:09
| Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Duration |
Post Insult Type |
Post Insult Time Value |
Post Insult Time Unit |
Clinical Measurement Notes |
Record ID |
Study ID |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
inguinal fat pad mass |
male |
126.0 days
| 7 |
795.02 |
mg/mm |
41.33 |
109.35 |
post excision weight measurement |
0.0 |
|
|
|
if/tl |
101908 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
inguinal fat pad mass |
male |
91.0 days
| 13 |
1482.16 |
mg/mm |
53.88 |
194.27 |
post excision weight measurement |
0.0 |
|
|
|
if/tl |
101991 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
inguinal fat pad mass |
male |
91.0 days
| 7 |
1105.49 |
mg/mm |
59.28 |
156.84 |
post excision weight measurement |
0.0 |
|
|
|
if/tl |
101781 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
inguinal fat pad mass |
female |
91.0 days
| 7 |
155.0 |
mg/mm |
14.0 |
37.04 |
post excision weight measurement |
0.0 |
ovariectomy |
42 |
days |
sf/tl |
101706 |
2622 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
inguinal fat pad mass |
male |
91.0 days
| 13 |
1448.07 |
mg/mm |
60.58 |
218.42 |
post excision weight measurement |
0.0 |
|
|
|
if/tl |
101990 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
inguinal fat pad mass |
female |
91.0 days
| 8 |
209.0 |
mg/mm |
12.0 |
33.94 |
post excision weight measurement |
0.0 |
ovariectomy |
42 |
days |
sf/tl |
101705 |
2622 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
inguinal fat pad mass |
male |
91.0 days
| 12 |
765.81 |
mg/mm |
23.86 |
82.65 |
post excision weight measurement |
0.0 |
|
|
|
if/tl |
101782 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
vehicle control condition (0.5 %) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
inguinal fat pad mass |
male |
91.0 days
| 13 |
1501.32 |
mg/mm |
68.53 |
247.09 |
post excision weight measurement |
0.0 |
|
|
|
if/tl |
101989 |
2644 |
|